David H Spencer
Overview
Explore the profile of David H Spencer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
5349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Akkad N, Kodgule R, Duncavage E, Mehta-Shah N, Spencer D, Watkins M, et al.
Aesthet Surg J
. 2022 Nov;
43(3):318-328.
PMID: 36351182
Background: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare malignancy originating from the periprosthetic capsule of a textured, most often macrotextured, breast implant. Identified in women whose indications...
12.
Menssen A, Khanna A, Miller C, Nonavinkere Srivatsan S, Chang G, Shao J, et al.
Blood Cancer Discov
. 2022 Jun;
3(4):330-345.
PMID: 35709710
Significance: Subclone expansion is a hallmark of progression from MDS to secondary AML. Subclonal signaling gene mutations are common at MDS (often at low levels), show complex and convergent patterns...
13.
Mitchell E, Spencer Chapman M, Williams N, Dawson K, Mende N, Calderbank E, et al.
Nature
. 2022 Jun;
606(7913):343-350.
PMID: 35650442
Age-related change in human haematopoiesis causes reduced regenerative capacity, cytopenias, immune dysfunction and increased risk of blood cancer, but the reason for such abrupt functional decline after 70 years of...
14.
Hou Y, Neidich J, Duncavage E, Spencer D, Schroeder M
Hum Mutat
. 2022 Apr;
43(11):1519-1530.
PMID: 35471774
Characterizing the genomic landscape of cancers is a routine part of clinical care that began with the discovery of the Philadelphia chromosome and has since coevolved with genomic technologies. Genomic...
15.
Berrien-Elliott M, Foltz J, Russler-Germain D, Neal C, Tran J, Gang M, et al.
Sci Transl Med
. 2022 Feb;
14(633):eabm1375.
PMID: 35196021
Natural killer (NK) cells are innate lymphoid cells that eliminate cancer cells, produce cytokines, and are being investigated as a nascent cellular immunotherapy. Impaired NK cell function, expansion, and persistence...
16.
Miller C, Walker J, Jensen T, Hooper W, Fulton R, Painter J, et al.
J Mol Diagn
. 2022 Jan;
24(3):219-223.
PMID: 35041928
The U2AF1 gene is a core part of mRNA splicing machinery and frequently contains somatic mutations that contribute to oncogenesis in myelodysplastic syndrome, acute myeloid leukemia, and other cancers. A...
17.
Wilson E, Helton N, Heath S, Fulton R, Payton J, Welch J, et al.
Leukemia
. 2021 Dec;
36(4):935-945.
PMID: 34873300
Recurrent mutations in IDH1 or IDH2 in acute myeloid leukemia (AML) are associated with increased DNA methylation, but the genome-wide patterns of this hypermethylation phenotype have not been comprehensively studied...
18.
Ferraro F, Miller C, Christensen K, Helton N, OLaughlin M, Fronick C, et al.
Proc Natl Acad Sci U S A
. 2021 Nov;
118(49).
PMID: 34845035
Acute myeloid leukemia (AML) patients rarely have long first remissions (LFRs; >5 y) after standard-of-care chemotherapy, unless classified as favorable risk at presentation. Identification of the mechanisms responsible for long...
19.
Ferris M, Smith A, Heath S, Duncavage E, Oberley M, Freyer D, et al.
Blood
. 2021 Nov;
139(3):461-464.
PMID: 34788385
No abstract available.
20.
Christopher M, Katerndahl C, LeBlanc H, Elmendorf T, Basu V, Gang M, et al.
Haematologica
. 2021 Oct;
107(1):342-346.
PMID: 34670359
No abstract available.